Tempo Group Syosset

Tempo Group Syosset

Services:
Type of Care
• Substance use treatment

Age Groups Accepted

• Children/Adolescents

Transitional Services

• Outcome follow-up after discharge
• Discharge Planning
• Aftercare/continuing care
• Naloxone and overdose education

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Testing

• Drug or alcohol urine screening
• Drug and alcohol oral fluid testing

Type of Opioid Treatment

• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Prescribes naltrexone
• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere

Facility Smoking Policy

• Smoking not permitted

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support
• Hepatitis education, counseling, or support
• Group counseling
• Individual counseling
• Smoking/vaping/tobacco cessation counseling
• Marital/couples counseling
• Family counseling
• Substance use disorder education

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment

License/Certification/Accreditation

• State Substance use treatment agency

Treatment Approaches

• Anger management
• Trauma-related counseling
• Substance use disorder counseling
• Cognitive behavioral therapy
• Motivational interviewing
• Brief intervention
• Telemedicine/telehealth therapy
• Relapse prevention
• 12-step facilitation

Language Services

• Other languages (excluding Spanish)

Other Languages

• Creole
• Italian

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Ancillary Services

• Mental health services

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• No formal relationship with prescribing entity
• Other contracted prescribing entity

Facility Vaping Policy

• Vaping not permitted

Gender Accepted

• Female
• Male

Assessment/Pre-treatment

• Outreach to persons in the community
• Comprehensive substance use assessment
• Interim services for clients
• Screening for tobacco use
• Screening for substance use
• Screening for mental disorders

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicaid
• Private health insurance
• State-financed health insurance plan other than Medicaid
• SAMHSA funding/block grants
• Federal, or any government funding for substance use treatment programs
• Medicare

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Buprenorphine with naloxone
• Clonidine
• Medication for mental disorders
• Acamprosate (Campral®)
• Naltrexone (oral)
• Buprenorphine without naloxone
• Disulfiram
• Lofexidine
• Nicotine replacement

Special Programs/Groups Offered

• Adult men
• Adolescents
• Adult women
• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma
• Young adults

Recovery Support Services

• Assistance with obtaining social services
• Mentoring/peer support
• Self-help groups

External Opioid Medications Source

• In-network prescribing entity
• Other contracted prescribing entity
• No formal relationship with prescribing entity